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Acute eVects of urban air pollution on respiratory
health of children with and without chronic
respiratory symptoms
Saskia C van der Zee, Gerard Hoek, H Marike Boezen, Jan P Schouten,
Joop H van Wijnen, Bert Brunekreef
Abstract
Objectives—To investigate to what extent
diVerent components of air pollution are
associated with acute respiratory health
eVects in children with and without
chronic respiratory symptoms.
Methods—During three consecutive win-
ters starting in 1992–3, peak expiratory
flow (PEF) and respiratory symptoms
were registered daily in panels of children
of 7–11 years old with and without symp-
toms, living in urban areas with high traf-
fic intensity in The Netherlands.
Simultaneously, panels of children living
in non-urban areas were studied. Daily
measurements of particles with aerody-
namic diameter <10 µm (PM10), black
smoke (BS), sulphate, SO2, and NO2 were
performed in both areas.
Results—The contrast in particle concen-
trations (PM10, BS, and sulphate) between
urban and non-urban areas was small, but
there was more contrast in the concentra-
tions of SO2 and NO2. In children with
symptoms from both areas, significant
associations were found between PM10,
BS, and sulphate concentrations and the
prevalence of symptoms of the lower
respiratory tract (LRS) and decrements in
PEF. Particle concentrations were also
associated with use of bronchodilators in
the urban areas, but not in the non-urban
areas. After stratification by use of medi-
cation, stronger associations were found
in children who used medication than in
children who did not use medication. The
magnitude of the estimated eVects was in
the order of a twofold increase in the use
of bronchodilators, a 50% increase in LRS,
and an 80% increase in decrements in PEF
for a 100 µg/m3 increase in the 5 day mean
PM10 concentration. In children without
symptoms, significant associations were
found between concentrations of PM10 and
BS and decrements in PEF in both areas,
but these associations were smaller than
those for children with symptoms. No
associations with respiratory symptoms
were found.
Conclusions—The results suggest that
children with symptoms are more suscep-
tible to the eVects of particulate air pollu-
tion than children without symptoms, and
that use of medication for asthma does not
prevent the adverse eVects of particulate
air pollution in children with symptoms.
(Occup Environ Med 1999;56:802–812)
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Severe episodes of air pollution in winter in the
past have been associated with serious health
eVects, such as increased hospital admissions
and mortality.1 Over the past decades, concen-
trations of traditional winter air pollution com-
ponents such as SO2 and airborne coarse
particulates have decreased in the Netherlands
and other European countries. This decrease
can be ascribed to emission abatement meas-
ures and changes in energy production for
industrial processes and space heating. Con-
centrations of other pollutants such as NO2 and
O3 have increased during the same period,
mostly due to higher intensity of motorised
traYc. Motorised traYc also plays an impor-
tant part in the formation of particulate air
pollution, both directly and indirectly through
the formation of secondary aerosols.2 Recent
studies have shown that current concentrations
of particulate air pollution are associated with
adverse health outcomes, even at concentra-
tions well below the 1987 World Health
Organisation air quality guidelines for
Europe.3 4
Also in The Netherlands associations were
reported between low levels of winter air pollu-
tion and respiratory health among children.5–7
However, those studies have mainly been con-
ducted in non-urban areas. It was not clear to
what extent such associations would be diVer-
ent in urban areas where the contribution of
local sources to the air pollution mixture is
greater than in non-urban areas.
The uncertainties surrounding acute eVects
of episodes of winter smog in large urban areas
led us to perform a large epidemiological win-
ter smog study that was conducted during
three consecutive winters starting in 1992–3.
The study was designed to compare acute
health eVects of winter air pollution in selected
panels of children and adults, with and without
chronic respiratory symptoms, living in urban
and non-urban areas. This paper describes the
results for the groups of children. The results
for the groups of adults will be described in a
separate paper.
Methods
STUDY DESIGN
The study was carried out during three
consecutive winters starting in 1992–3. Dur-
ing each winter, panels of children, 7–11 years
old, with and without chronic respiratory
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symptoms were selected from an urban and a
non-urban area. The children were selected
from the general population of children with a
screening questionnaire. During the 3 month
study periods daily measurements of peak
expiratory flow (PEF) were made, and the
occurrence of acute respiratory symptoms and
use of bronchodilators was registered in a daily
diary. Air pollution was monitored daily on
central sites in each community.
STUDY POPULATION
Study areas chosen were: Rotterdam and
Bodegraven/Reeuwijk (1992–3), Amsterdam
and Meppel (1993–4), and Amsterdam and
Nunspeet (1994–5). Figure 1 shows the
locations of the areas. The Netherlands is a
country with a very high population density.
The southern, and especially the western parts,
are most urbanised. The northeastern part has
a relatively low population density. All major
cities are located in the western part. Rotter-
dam is an industrialised city with about
600 000 inhabitants. It is in the centre of the
Rijnmond area (a conglomeration of industrial
cities). Amsterdam (720 000 inhabitants) has a
relatively small industrial area; local air pollu-
tion is caused primarily by emissions from
motorised traYc. As well as local air pollution,
transport of air pollution from other parts of
the Netherlands and from other European
countries contributes to the levels of air pollu-
tion in Dutch cities.
For the urban panels the objective was to
select children with high exposure to air pollu-
tion related to traYc. Therefore, in both
Rotterdam and Amsterdam areas in the inner
city were selected with a high traYc intensity
and a high population density, but with no
industrial sources.
The non-urban panels were selected from
communities which had no major traYc emis-
sions, no large industrial sources, and had suf-
ficient size to select enough children.
During the first winter (1992–3) we selected
a non-urban area close to (about 30 km) the
urban area. During the second and third
winters we selected the non-urban areas
further from the urban area to try to maximise
the contrast in air pollution, which was found
to be small in the first winter.
Screening questionnaires were used to ob-
tain information on chronic respiratory symp-
toms. The questionnaires were distributed
through the schools or by mail to all children
aged 7–11 years, and had to be filled out and
returned by their parents. The screening ques-
tionnaire was an adapted version of questions
from the World Health Organisation question-
naire for children.8 During the first winter
(1992–3), a slightly diVerent questionnaire was
used. The reason for this was that during the
winter of 1993–4, the study was performed in
the framework of the pollution eVects of
asthmatic children in Europe (PEACE) study
and thus the PEACE protocol was followed.9
Children were considered to have symptoms if
they had a positive answer to one or more of the
screening questions listed in table 1. Children
without any reported symptoms on the screen-
ing questionnaire were considered not to have
symptoms. Children with and without symp-
toms were selected randomly from those who
met the selection criteria. Target panel size was
75 children for each panel, both with and with-
out symptoms, during the winters of 1992–3
and 1993–4. During the winter of 1994–5 tar-
get panel size was 60 children with symptoms
and 40 children without symptoms. The study
was approved by the medical ethics committee
of the Groningen University Hospital and the
medical ethics committee of the Municipal
Health Service in Amsterdam. Informed con-
sent was signed by the parents of all children.
Location of the study areas during the three winters.
1=Rotterdam (urban area 1992–3), 2=Bodegraven/
Reeuwijk (non-urban area 1992–3), 3=Amsterdam
(urban area 1993–4 and 1994–5), 4=Meppel (non-urban
area 1993–4), 5=Nunspeet (non-urban area 1994–5).
1
2
3
4
5
The Netherlands
Germany
North
Sea
Belgium
= 30 km
Table 1 Selection of questions from the screening questionnaire for the three winters
1992–3 1993–4 and 1994–5
Recent asthma Has your child been bothered in the past year by attacks of
shortness of breath with wheezing?
Has your child been bothered in the past 12 months by attacks
of shortness of breath with wheezing?
Chronic cough Does your child cough like this almost daily for three months
a year? (This question follows two other questions on cough
during the day or night, on most days during the autumn
and winter season)
Has your child had a dry cough at night in the past 12 months,
apart from coughing with a cold or chest infection?
Doctor diagnosed asthma Has a doctor ever said your child has asthma? Has a doctor ever said your child has asthma?
Recently treated by a specialist
for asthma
Has your child been treated for asthma by a specialist during
the past year?
—
Recent wheeze — Has your child been bothered in the past 12 months by a
wheezy chest, apart from a cold?
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EXPOSURE ASSESSMENT
Twenty four hour measurements of particles
with aerodynamic diameter of <10 µm (PM10)
and black smoke (BS) were made at fixed sites
in both the urban and non-urban areas. Also,
24 hour measurements of non-organic second-
ary aerosols (sulphate, nitrate, and ammo-
nium) and aerosol acidity were made. Meas-
urements were from 1500 on one day to 1500
on the next. The particle measurement sites
were chosen so that they were close to the resi-
dences of the participating children, and not
strongly influenced by local sources such as
traYc and industry in the direct vicinity (back-
ground sites). Information about the ambient
concentrations of SO2 and NO2 in Rotterdam
was obtained from a city background station of
the National Air Quality Monitoring Network,
operated by the National Institute of Public
Health and Environmental Protection. In
Amsterdam, information was obtained from a
city background station of the Air Quality
Monitoring Network operated by the Environ-
mental Research Institute of the City of
Amsterdam.Data for the non-urban areas were
obtained from the nearest measurement sites of
the National Air Quality Monitoring Network,
located in Zegveld, Witteveen, and Lelystad
during the three consecutive winters. Those
measurement sites were about 10, 40, and 30
km away from the non-urban areas, respec-
tively. The SO2 and NO2 concentrations were
provided as 1 hour means and transformed into
24 hour average concentrations from 1500–
1500. More information about the methods of
measurement is reported elsewhere.10
Temperature was measured at 1 hourly
intervals and the minimum between 1500 and
1500 was recorded. Data for the urban areas
were obtained from Rotterdam and Amster-
dam airports, respectively. Data for the non-
urban areas in the three consecutive winters
were obtained from Zegveld, Eelde, and Lelys-
tad, 10, 40, and 30 km away from the
non-urban areas.
Data on the weekly incidence of influenza
and influenza-like illness were obtained from
the Dutch Institute of Primary Health Care
(NIVEL). A detailed analysis of the incidence
data for the influenza-like illness relative to the
health data collected in our groups will be
reported elsewhere (unpublished data).
HEALTH MEASUREMENTS
During the study period, participants per-
formed PEF measurements twice daily with
Mini Wright peak flow meters, once in the
morning before breakfast and once in the
evening before going to bed. Subjects were
instructed to perform the PEF measurements
before any airway medication was taken. Every
test consisted of three manoeuvres and partici-
pants were asked to note all three readings in a
diary. The highest of the three PEF readings
was used for analysis.
The diary was also used to register the
occurrence of acute respiratory symptoms and
use of medication. Symptoms included in the
diary were cough, phlegm, runny or stuVed
nose, woken up with breathing problems,
shortness of breath, wheeze, and attacks of
shortness of breath with wheeze and fever.
During the winters of 1993–4 and 1994–5, the
symptoms eye irritation and sore throat were
included as well. Subjects were instructed to
indicate whether the symptoms were absent,
slight, or moderate to severe on each day. To
assess use of medication, subjects had to write
down the name of the medication and the
number of units taken.The use of the diary and
Mini Wright meter was demonstrated during a
home visit in the presence of the child and at
least one of the parents.
DATA ANALYSIS
All panels were analysed separately. Next,
combined eVect estimates were calculated for
children with and without symptoms, and for
urban and non-urban areas separately.
For each subject, the first 2 days of measure-
ment were removed to eliminate a possible
training eVect. Subjects with missing diary
information (PEF or symptoms) on >40% of
the days were removed from the dataset. All
statistics were analysed with SAS.12
For the analysis of PEF data, a diVerent
approach was used compared with other panel
studies, including the PEACE study.5 9 13 14
Those studies were focusing on population
average responses, whereas our approach was
focusing on the fraction of children experiencing
substantial decrements in PEF. A comparison
between the two approaches is described by
Hoek et al.15 In short, it shows that small decre-
ments in population mean PEF are accompa-
nied by large increases in the fraction of children
that have a substantial decrease in PEF.
For each individual child the median morn-
ing and evening PEF was calculated. Percent-
age morning decrements were calculated for
each measurement day for each subject by sub-
tracting the individual median of morning PEF
from the morning PEF measured on that day
and dividing the diVerence by the individual
median of morning PEF. The prevalence of
morning decrements larger than 10% and 20%
respectively was calculated as the number of
children experiencing such a decrement di-
vided by the total number of children reporting
valid PEF measurements on each day of study.
The percentage evening decrements were
calculated the same way.
After recoding the symptoms in the diary,
0=no symptom and 1=slight or moderate to
severe symptoms, daily prevalence was calcu-
lated for each panel as the fraction of children for
whom presence of a respiratory symptom was
reported, with data only from those children
with nomissing information in the diary for each
separate day.The symptoms shortness of breath,
wheeze, and attacks of shortness of breath with
wheeze were combined as symptoms of the
lower respiratory tract (LRSs). Cough was ana-
lysed separately. Runny or stuVed nose and sore
throat were combined as symptoms of the upper
respiratory tract (URS). Medication use was
divided into bronchodilators—such as sal-
butamol, fenoterol, terbutalin—maintenance
medication—such as cromoglycate, theophyllin,
anti-histaminica and inhaled corticosteroids—
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and other medication, and was recoded as 0 (no
use of medication) or 1 (any use of medication),
for bronchodilators and maintenance medi-
cation separately. For the study reported here,
only LRS, URS, cough, phlegm, and use of
bronchodilators were analysed.
The explanatory variables were 24 hour
mean concentration of PM10, BS, SO2, NO2,
sulphate, and nitrate, analysed separately.
Concentration for the current day (lag 0), pre-
vious day (lag 1), 2 days before (lag 2), and the
mean concentration of 0–4 days before (5 day
mean) were analysed separately.
The association between air pollution and
the prevalence of decrements in PEF, symp-
toms, and use of bronchodilators was evaluated
with logistic regression with the PROC
MODEL, but under the assumption of nor-
mally distributed residuals. This was done
because when a binomial distribution was
assumed the residuals showed considerable
underdispersion. The number of subjects
reporting on each day was used for weighting,
and correction for autocorrelation of residuals
was made assuming a first order autoregressive
structure. Minimum daily temperature, an
indicator variable for day of week (school day
versus weekend or holiday), time trend, and the
incidence of influenza and influenza-like illness
in the general population were included in the
model as potential confounders. Time trend
was included as a linear, quadratic, and cubic
term because in most panels strong non-linear
time trends were found in the prevalence of
symptoms, use of medication, and decrements
in PEF.
The incidence of influenza-like illness, regis-
tered by the Dutch network of sentinel stations,
was included in the model with two variables
representing respectively the mean incidence of
0–6 days earlier and 7–13 days earlier. A moti-
vation of the selection of these variables, as well
as an association between incidence of
influenza-like illness and respiratory health in
the groups will be reported elsewhere.11
Combined eVect estimates were calculated
for panels of children with and without
symptoms, and for urban and non-urban areas
separately, with the regression slopes from the
panel specific logistic regression models for the
three winters. Combined eVect estimates were
calculated as the weighted mean of the panel
specific slopes, with the weights being the
inverse of the group specific variances of the
slopes. The SEM of the combined slope was
calculated as the inverse of the square root of
the sum of weights. Odds ratios (ORs) were
calculated for an increase of 100 µg/m3 in PM10
concentration, an increase of 40 µg/m3 in BS,
SO2 and NO2 concentration and an increase of
15 µg/m3 in sulphate concentration.
To test whether the association between air
pollution and respiratory health diVered sig-
nificantly between urban and non-urban areas,
a weighted linear regression was performed
with the group specific regression slopes as the
dependent variable and an indicator for area
(urban v non-urban area) as the independent
variable. The inverse of the group specific vari-
ances of the slopes were used for weighting.
The weighted regression analysis was per-
formed for children with and without symp-
toms separately.
Multiple regression models including two
pollutants simultaneously have been specified
for the symptomatic groups, in an attempt to
separate eVects from specific components of
the air pollution mixture. This was done for the
following combinations of pollutants: PM10 and
SO2, PM10 and BS, PM10 and sulphate, and BS
and sulphate. The same lags were evaluated
simultaneously for both pollutants.
Results
From the 12 331 screening questionnaires
handed out during the three winters, 5770
(47%) were returned. The response was
slightly lower in the urban areas (42%) than in
the non-urban areas (52%). Of the 5770
children who returned questionnaires, 931
(16%) were eligible and willing to participate
in the groups with symptoms, whereas 1198
(21%) were eligible and willing to participate
in the groups without symptoms. From the 396
children with and 399 children without symp-
toms that were enrolled, respectively 320 and
313 were included in the final analysis.
In table 2 some characteristics of the groups
are shown. Chronic cough was the screening
symptom with the highest prevalence in the
groups with symptoms. The prevalence of
>10% decrements in evening PEF was on
average 10.6% in the groups with symptoms
and 8.3% in the groups without symptoms.
Symptomatic groups had a higher prevalence
of acute respiratory symptoms than groups
without symptoms.
In urban groups with symptoms the preva-
lence of maintenance medication was almost
twofold lower than in non-urban groups with
symptoms (8.5% and 15.5%, respectively).
Use of bronchodilators was not reported in the
panels without symptoms during the three
winters. Lower respiratory symptoms (LRS)
were rarely reported in the panels without
Table 2 Characteristics of the panels
Symptoms No symptoms
Urban area Non-urban area Urban area Non-urban area
Original sample size 193 203 196 203
Final sample size* 142 178 137 176
Winter 1992–3 31 48 43 60
Winter 1993–4 55 71 56 77
Winter 1994–5 56 59 38 39
Prevalence of screened symptoms and use of medication (% of final sample):
Recent wheeze 44 46 0 0
Recent asthma 29 37 0 0
Chronic cough 83 71 0 0
Doctor diagnosed asthma 26 38 0 0
Daily medication use 16 24 0 0
Mean daily prevalence (%) of symptoms, use of medication, PEF decrements, and mean PEF†:
Lower respiratory tract 8.4 9.1 0.8 1.1
Upper respiratory tract 37 35 21 23
Cough 35 35 16 18
Phlegm 15 19 7.4 6.3
Use of bronchodilator 4.8 3.4 — —
Use of Maintenance medication 8.5 15.5 — —
>10% Decrements in evening PEF 10.5 10.8 9.4 7.3
Mean evening PEF (l/min) 329 329 346 358
*Smaller than original sample size because subjects with >40% of the diary information missing
were excluded.
†Pooled prevalences and PEF were calculated as the mean of the subject specific prevalences and
PEF, weighted for the number of person-days that each group contributed.
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symptoms; during the winters of 1992–3 and
1994–5, the panel specific prevalences of LRS
were too low to be analysed. Only during the
winter of 1993–4 was the mean panel specific
prevalence of LRS relatively high (1.2% in the
urban area and 2.0% in the non-urban area).
Table 3 shows the results of the air pollution
measurements. The median concentrations of
PM10 and BS were only slightly higher in the
urban areas than in the non-urban areas. There
was more contrast in the concentration of the
gaseous pollutants SO2 and NO2. The median
concentration of sulphate was slightly lower in
the urban than in the non-urban areas.
Concentrations of aerosol acidity were very low
during the three winters (not shown). Only a
few concentrations were above the detection
limit (0.10 µg/m3) and therefore, concentra-
tions of aerosol acidity were not used in further
analyses.
During the winters of 1992–3 and 1993–4,
episodes of air pollution occurred resulting in
increased concentrations of particles in both
the urban and non-urban areas. During the
winter of 1994–5 no episodes of air pollution
occurred as a result of mild meteorological
conditions. For a more detailed description of
the air pollution concentrations and episodes
we refer to another paper.10
Spearman correlations between the various
air pollutants and potential confounding vari-
ables were calculated separately for the urban
and non-urban areas during the three winters
(not shown). During the first two winters,
when episodes of air pollution occurred, a high
correlation (R>0.7) was found between PM10
and the other indicators of particulate air
pollution BS and sulphate. The correlation
between SO2 and indicators of particulate air
pollution varied between 0.5 and 0.8 and was
slightly higher than the correlation between
NO2 and indicators of particulate air pollution
(except for BS). The correlation between SO2
and NO2 was about 0.5. During the winter of
1994–5, the correlations were lower than these
between all air pollutants. There were no clear
diVerences in correlations between urban and
non-urban areas. Air pollutants and tempera-
ture were moderately highly correlated,
whereas low correlations were found between
air pollutants and the potential confounders
day of study and incidence of influenza-like ill-
ness.
Table 4 shows the associations between indi-
ces of air pollution and the prevalence of >10%
decrements in evening PEF, respiratory symp-
toms, and use of bronchodilators in children
with symptoms. In the urban areas, the preva-
lence of >10% decrements in evening PEF,
LRS, and use of bronchodilators was positively
associated with PM10, BS, and sulphate. Many
associations reached significance. Also, SO2
was positively associated with those indicators
of respiratory health but less consistently than
the particulate pollutants. NO2 was positively
associated with use of bronchodilators but not
with LRS or >10% decrements in evening
PEF. No associations were found between
indices of air pollution and the prevalence of
URS and cough. Also, no associations were
found between phlegm and the prevalence of
>10% decrements in morning PEF (not
shown).
In the non-urban areas, associations between
particle concentrations and >10% decrements
in evening PEF and LRS were in the same
direction as in the urban areas, but significant
associations were reached less often. As op-
posed to what was found in the urban areas,
particle concentrations were not consistently
associated with use of bronchodilators. How-
ever, the diVerences in eVect estimates between
urban and non-urban groups were generally
small and the 95% confidence intervals (95%
CIs) showed considerable overlap. There was
essentially no association between SO2 and
NO2 in the non-urban areas. The prevalence of
>10% decrements in morning PEF showed a
consistent positive association with PM10 and
BS (not shown in table 5). Significant associa-
tions were found with lag 2 and 5 day mean
concentrations, and for BS also with previous
day concentration. For example, ORs for lag 2
of PM10 and BS were 1.23 (95% CI 1.01 to
1.50) and 1.26 (95% CI 1.06 to 1.49), respec-
tively.
Both in the urban and the non-urban areas,
5 day mean concentrations seemed to be more
closely related to respiratory health indicators
than present day or lagged exposure variables.
Separate analyses for children who did and
did not use medication were conducted to
evaluate diVerences in response to air pollu-
tion. For this purpose, children were divided
into those who did or did not report use of
bronchodilators or maintenance medication
during the study period. Table 5 presents the
associations between PM10 concentrations and
evening PEF, LRS, and use of bronchodilators
after stratification for use of medication. It
shows that in the urban panels, PM10 is strongly
associated with LRS in the children who used
Table 3 Air pollution, temperature, and incidence of influenza like illness
Median and maximum 24 h mean concentrations (µg/m3) Minimum hourly
temperature (°C) of 24 h
values (median (range))
Incidence/10 000
subjects of influenza
like illness in previous
week (median (range))Study period Days (n) PM10 Black smoke Sulphate SO2 NO2
1992–3:
Urban 22/1/93–19/4/93 88 48 (146) 15 (56) 5.3 (17) 23 (152) 51 (94) 4.2 (−2.9, 9.8) 37 (10, 67)
Non-urban 21/1/93–19/4/93 89 35 (104) 10 (38) 5.9 (15) 8.9 (43) 33 (83) 2.8 (−4.4, 9.8) 23 (5, 65)
1993–4:
Urban 3/11/93–6/3/94 124 37 (123) 12 (65) 2.7 (24) 11 (34) 48 (76) 2.7 (−8.1, 10.0) 9 (0, 122)
Non-urban 17/11/93–6/3/94 110 35 (242) 10 (58) 2.8 (23) 5.0 (42) 25 (54) 1.0 (−10.9, 9.3) 3 (0, 56)
1994–5:
Urban 25/11/94–5/3/95 101 29 (90) 6.9 (28) 1.7 (10) 6.0 (24) 47 (82) 3.8 (−5.0, 11.5) 2 (0, 10)
Non-urban 23/11/94–5/3/95 103 24 (97) 5.8 (43) 1.9 (18) 3.6 (17) 22 (57) 3.1 (−11.1, 11.3) 2 (0, 20)
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medication, but not in the children who did not
use medication. Conversely, the association
between PM10 and decrements in evening PEF is
not more pronounced in children who used
medication. Children who used medication
reported significantly more LRS and use of
bronchodilators with increasing PM10 concen-
tration in the urban areas, but not in the
non-urban areas. Although results are only
presented for PM10, similar results were found
for BS and to a lesser extent for SO2.
The associations between indices of air pollu-
tion and indicators of respiratory health in chil-
dren without symptoms are presented in table 6.
In both the urban and non-urban areas, indices
of air pollution were positively associated with
the prevalence of >10% decrements in evening
PEF. The most consistent associations were
found for PM10 and BS. Positive associations
were also found between indices of air pollution
and the prevalence of >10% decrements in
morning PEF in the urban areas, but not in the
non-urban areas (not shown). No associations
were found between indices of air pollution and
the prevalence of cough, phlegm, and URS in the
urban areas. In the non-urban areas, there was
an unexpected tendency towards associations in
the direction of lower prevalence of cough with
higher concentrations of air pollution for all pol-
lutants except sulphate. There were no signifi-
cant diVerences between the ORs in urban and
non-urban areas. By contrast with the findings
among the children with symptoms, significant
associations among the children without symp-
toms were mainly found at 0 and 1 day lags, and
not with the 5 day means as exposure variables.
In the panels without symptoms, the prevalence
of LRS was so low that analyses resulted in
extreme eVect estimates and SEMs in all winters
except 1993–4, when the mean prevalence was
relatively high. The combined eVect estimates
for the three winters were (nearly) identical to
the panel specific eVect estimates for the winter
of 1993–4, as the other winters hardly contrib-
uted to the weighting. Therefore, the associa-
tions with LRS are not presented in the tables.
However, in the winter of 1993–4, a generally
positive correlation between particle indices and
respiratory health was found, especially in the
non-urban panel where the eVect estimates were
more stable due to the higher prevalence. For
example, the eVect estimates for LRS in associ-
ation with PM10 (lag 1) were 1.44 (95% CI 0.54
to 3.83) in the urban area and 1.58 (95% CI
1.06 to 2.35) in the non-urban area.
The association between nitrate concentration
and respiratory health was also analysed. How-
ever, due to the high correlation with sulphate (R
between 0.75 and 0.87) the eVect estimates for
nitrate were nearly identical to those for
sulphate, and therefore, the results are not
presented. Sulphate was chosen to serve as an
indicator for secondary aerosols, representing
particles that mainly result from long distance
transport.
Table 7 presents the associations between
indices of air pollution and selected respiratory
health indicators in children with symptoms in
urban areas, calculated from two pollutant mod-
els. In two pollutant models where PM10 and SO2Ta
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Table 6 Odds ratios (ORs) (95% CIs) for the association between air pollution and the prevalence of >10% decrements in evening PEF, acute respiratory
symptoms, and use of bronchodilators in children without symptoms, calculated from combined eVect estimates
Urban areas Non-urban areas
Evening PEF URS Cough Evening PEF URS Cough
PM10:
Lag 0 1.32 (1.04 to 1.67)* 1.07 (0.87 to 1.31) 1.09 (0.90 to 1.31) 1.40 (1.09 to 1.80)* 1.13 (1.00 to 1.28) 1.00 (0.91 to 1.11)
Lag 1 1.06 (0.84 to 1.34) 1.08 (0.88 to 1.32) 0.92 (0.76 to 1.11) 1.30 (1.03 to 1.64)* 0.95 (0.83 to 1.08) 0.88 (0.80 to 0.97)*
Lag 2 1.15 (0.93 to 1.42) 0.97 (0.80 to 1.19) 0.94 (0.79 to 1.13) 1.14 (0.90 to 1.44) 0.87 (0.77 to 0.99)* 0.95 (0.86 to 1.04)
5 Day mean 1.27 (0.93 to 1.74) 1.06 (0.71 to 1.59) 0.90 (0.64 to 1.27) 1.41 (0.93 to 2.14) 0.86 (0.63 to 1.17) 0.96 (0.81 to 1.14)
Black smoke:
Lag 0 1.45 (1.12 to 1.87)* 1.09 (0.88 to 1.36) 0.92 (0.75 to 1.12) 1.60 (1.29 to 2.00)* 1.04 (0.90 to 1.20) 0.94 (0.84 to 1.05)
Lag 1 1.13 (0.90 to 1.43) 1.17 (0.96 to 1.43) 1.06 (0.88 to 1.27) 0.92 (0.76 to 1.12) 0.98 (0.86 to 1.12) 0.90 (0.82 to 0.99)*
Lag 2 1.26 (1.03 to 1.54)* 0.91 (0.74 to 1.11) 1.05 (0.88 to 1.25) 1.14 (0.94 to 1.38) 0.90 (0.79 to 1.03) 0.92 (0.83 to 1.01)
5-day mean 1.42 (1.01 to 1.99)* 1.18 (0.78 to 1.80) 0.99 (0.71 to 1.38) 1.14 (0.80 to 1.76) 0.92 (0.67 to 1.24) 0.87 (0.74 to 1.03)
Sulphate:
Lag 0 1.15 (0.87 to 1.51) 1.21 (0.97 to 1.51) 1.09 (0.89 to 1.34) 1.33 (0.95 to 1.86) 1.09 (0.90 to 1.32) 1.17 (1.01 to 1.35)*
Lag 1 1.11 (0.86 to 1.44) 0.97 (0.79 to 1.19) 0.87 (0.71 to 1.07) 0.93 (0.69 to 1.24) 0.96 (0.79 to 1.15) 1.05 (0.90 to 1.23)
Lag 2 1.10 (0.86 to 1.40) 1.06 (0.85 to 1.30) 1.10 (0.90 to 1.33) 1.19 (0.92 to 1.55) 0.96 (0.80 to 1.14) 0.95 (0.83 to 1.10)
5 Day mean 1.29 (0.87 to 2.15) 1.23 (0.75 to 2.01) 0.81 (0.52 to 1.26) 1.35 (0.63 to 2.88) 1.34 (0.98 to 1.84) 1.15 (0.86 to 1.53)
SO2:
Lag 0 1.13 (0.88 to 1.47) 0.92 (0.76 to 1.11) 0.93 (0.78 to 1.11) 1.10 (0.87 to 1.39) 1.07 (0.92 to 1.25) 0.86 (0.76 to 0.97)*
Lag 1 1.16 (0.90 to 1.50) 1.10 (0.91 to 1.34) 1.02 (0.84 to 1.23) 1.07 (0.85 to 1.35) 0.85 (0.72 to 1.00) 0.95 (0.83 to 1.08)
Lag 2 1.10 (0.87 to 1.39) 0.83 (0.70 to 0.99)* 0.97 (0.83 to 1.15) 1.10 (0.88 to 1.38) 0.94 (0.80 to 1.10) 0.94 (0.82 to 1.06)
5 Day mean 1.33 (0.89 to 2.00) 0.66 (0.42 to 1.03) 1.04 (0.69 to 1.57) 1.14 (0.66 to 1.96) 0.78 (0.52 to 1.18) 0.87 (0.68 to 1.12)
NO2:
Lag 0 1.13 (0.94 to 1.35) 1.05 (0.92 to 1.20) 1.02 (0.89 to 1.17) 1.14 (0.98 to 1.33) 1.03 (0.94 to 1.13) 0.93 (0.87 to 1.00)
Lag 1 1.14 (0.97 to 1.34) 0.97 (0.86 to 1.11) 0.91 (0.81 to 1.04) 1.08 (0.94 to 1.25) 0.97 (0.89 to 1.07) 0.90 (0.84 to 0.97)*
Lag 2 1.05 (0.89 to 1.23) 0.95 (0.84 to 1.08) 1.01 (0.89 to 1.14) 0.99 (0.85 to 1.15) 1.01 (0.92 to 1.09) 0.96 (0.90 to 1.03)
5 Day mean 1.17 (0.84 to 1.63) 1.08 (0.75 to 1.56) 1.05 (0.74 to 1.48) 1.21 (0.89 to 1.63) 0.98 (0.80 to 1.21) 0.93 (0.82 to 1.05)
*p<0.05, OR significantly diVerent from 1.
ORs for an increase of 100 µg/m3 in PM10, 40 µg/m
3 for black smoke, SO2, and NO2, and 15 µg/m
3 for sulphate.
Table 5 Odds ratios (ORs) (95% CIs) for the association between air pollution and the prevalence of >10% decrements in evening PEF, acute respiratory
symptoms, and use of bronchodilators in children with symptoms with and without medication, calculated from combined eVect estimates
Urban areas Non-urban areas
Evening PEF LRS Use of bronchodilator Evening PEF LRS Use of bronchodilator
Children with medication, PM10:
n=34 n=47
Lag 0 1.37 (0.81 to 2.31) 1.80 (1.17 to 2.75)* 1.44 (1.07 to 1.93)* 1.45 (0.93 to 2.25) 0.96 (0.76 to 1.22) 0.83 (0.59 to 1.17)
Lag 1 1.41 (0.86 to 2.32) 2.09 (1.43 to 3.07)* 1.30 (0.97 to 1.74) 1.37 (0.94 to 1.99) 1.09 (0.87 to 1.37) 1.04 (0.75 to 1.45)
Lag 2 1.40 (0.87 to 2.26) 1.72 (1.19 to 2.50)* 1.37 (1.02 to 1.83)* 1.33 (0.92 to 1.91) 1.04 (0.83 to 1.31) 1.07 (0.78 to 1.46)
5 Day mean 1.41 (0.68 to 2.94) 2.67 (1.52 to 4.70)* 2.25 (1.34 to 3.79)* 2.25 (1.05 to 4.81)* 1.24 (0.76 to 2.02) 0.75 (0.38 to 1.50)
Children without medication, PM10:
n=107 n=129
Lag 0 1.36 (0.92 to 2.00) 1.09 (0.76 to 1.56) — 1.20 (0.88 to 1.64) 0.94 (0.68 to 1.30) —
Lag 1 1.23 (0.86 to 1.75) 1.15 (0.80 to 1.63) — 1.00 (0.76 to 1.32) 0.78 (0.57 to 1.08) —
Lag 2 1.55 (1.12 to 2.13)* 1.31 (0.94 to 1.83) — 1.04 (0.80 to 1.36) 0.93 (0.69 to 1.24) —
5 Day mean 2.00 (1.15 to 3.47)* 1.24 (0.76 to 2.04) — 1.90 (1.10 to 3.30)* 3.70 (1.84 to 7.44)* —
*p<0.05, OR significantly diVerent from 1.
ORs for an increase of 100 µg/m3 in PM10, 40 µg/m
3 for black smoke, SO2, and NO2, and 15 µg/m
3 for sulphate.
Table 7 Odds ratios (ORs) (95% CIs) for the association between air pollution and the prevalence of >10% decrements in evening PEF, acute respiratory
symptoms, and use of bronchodilators in children with symptoms from the urban area, calculated from combined eVect estimates obtained in two pollutant
models
First pollutant Second pollutant
Evening PEF
Symptoms of the lower
respiratory tract Use of bronchodilator Evening PEF
Symptoms of the lower
respiratory tract
Use of
bronchodilator
PM10: SO2:
Lag 0 1.33 (0.95 to 1.87) 1.24 (0.91 to 1.68) 1.29 (0.97 to 1.71) Lag 0 1.14 (0.80 to 1.61) 1.29 (0.94 to 1.76) 0.95 (0.72 to 1.25)
Lag 1 1.45 (1.05 to 2.01)* 1.48 (1.10 to 1.99)* 0.84 (0.62 to 1.15) Lag 1 0.75 (0.51 to 1.09) 1.04 (0.75 to 1.46) 1.71 (1.26 to 2.32)*
Lag 2 1.22 (0.89 to 1.67) 1.27 (0.95 to 1.71) 1.29 (0.96 to 1.74) Lag 2 1.56 (1.13 to 2.13)* 1.05 (0.77 to 1.43) 0.94 (0.70 to 1.28)
5 Day mean 1.81 (1.04 to 3.16)* 1.46 (0.89 to 2.42) 1.84 (1.06 to 3.19)* 5 Day mean 1.03 (0.50 to 2.10) 1.13 (0.60 to 2.13) 0.76 (0.45 to 1.30)
PM10: Black smoke:
Lag 0 1.28 (0.85 to 1.93) 1.51 (1.04 to 2.18)* 1.16 (0.86 to 1.57) Lag 0 1.04 (0.71 to 1.55) 0.94 (0.65 to 1.36) 1.31 (0.98 to 1.75)
Lag 1 1.03 (0.69 to 1.56) 1.86 (1.30 to 2.67)* 1.33 (1.00 to 1.76)* Lag 1 1.04 (0.72 to 1.50) 0.76 (0.54 to 1.07) 1.05 (0.79 to 1.38)
Lag 2 1.59 (1.07 to 2.35)* 1.22 (0.84 to 1.78) 1.00 (0.74 to 1.34) Lag 2 0.85 (0.60 to 1.20) 1.14 (0.82 to 1.57) 1.34 (1.03 to 1.76)*
5 Day mean 0.74 (0.27 to 2.05) 1.80 (0.68 to 4.77) 2.49 (0.80 to 7.81) 5 Day mean 0.86 (0.37 to 1.86) 1.07 (0.47 to 2.42) 1.45 (0.58 to 3.64)
PM10: Sulphate:
Lag 0 1.39 (0.92 to 2.09) 1.61 (1.08 to 2.40)* 1.59 (1.13 to 2.24)* Lag 0 1.06 (0.73 to 1.55) 0.87 (0.61 to 1.25) 0.77 (0.55 to 1.06)
Lag 1 1.22 (0.78 to 1.88) 1.42 (0.98 to 2.07) 1.05 (0.74 to 1.49) Lag 1 0.97 (0.66 to 1.42) 1.02 (0.78 to 1.42) 1.11 (0.79 to 1.56)
Lag 2 1.32 (0.88 to 1.97) 1.24 (0.87 to 1.76) 1.27 (0.91 to 1.78) Lag 2 1.18 (0.84 to 1.67) 1.07 (0.78 to 1.47) 1.05 (0.76 to 1.44)
5 Day mean 1.11 (0.53 to 2.32) 1.76 (0.95 to 3.28) 2.21 (1.21 to 4.05)* 5 Day mean 1.58 (0.73 to 3.40) 1.21 (0.62 to 2.37) 0.95 (0.50 to 1.79)
Black smoke: Sulphate:
Lag 0 1.23 (0.83 to 1.83) 1.21 (0.85 to 1.72) 1.58 (1.20 to 2.09)* Lag 0 1.19 (0.82 to 1.73) 1.06 (0.76 to 1.49) 0.90 (0.67 to 1.20)
Lag 1 1.10 (0.77 to 1.58) 0.91 (0.65 to 1.27) 1.17 (0.88 to 1.56) Lag 1 1.03 (0.71 to 1.49) 1.32 (0.95 to 1.84) 1.04 (0.78 to 1.40)
Lag 2 0.94 (0.67 to 1.31) 1.17 (0.86 to 1.58) 1.32 (1.00 to 1.73)* Lag 2 1.37 (0.95 to 1.96) 1.09 (0.79 to 1.50) 0.93 (0.71 to 1.23)
5 Day mean 1.02 (0.49 to 2.10) 1.47 (0.82 to 2.62) 1.82 (0.90 to 3.68) 5 Day mean 1.96 (0.82 to 4.70) 1.23 (0.62 to 2.45) 1.10 (0.50 to 2.41)
*p<0.05, OR significantly diVerent from 1.
ORs for an increase of 100 µg/m3 in PM10, 40 µg/m
3 for black smoke, and SO2, and 15 µg/m
3 for sulphate.
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were included simultaneously, an independent
eVect of PM10 remained whereas no consistent
pattern was found for SO2. In models of PM10
with BS, and of PM10 with sulphate, the PM10
eVects generally remained, whereas the esti-
mates for BS and sulphate often became
non-significant. In models of BS with sulphate
no consistent pattern emerged. Two pollutant
models in the panels with symptoms from the
non-urban areas also indicated that the associa-
tions with PM10 were most consistent (not
shown), but the patterns were less clear than
for the urban panels, as less consistently
positive assocations were found in the one pol-
lutant models.
The associations with 5 day mean concentra-
tions generally became less consistent in the
two pollutant models, probably because of the
high correlation among these variables.
Discussion
In this study, we have found that in children
with symptoms who live in urban areas, the
daily prevalence of LRS, use of bronchodila-
tors, and decrements in evening PEF had a
consistent positive association with the concen-
tration of PM10, BS, and sulphate. There was
also a positive association with SO2, but not
with NO2. After stratification for use of
medication, the prevalence of LRS was strongly
associated with particle concentrations in chil-
dren who used medication, but not in children
who did not. In two pollutant models, when
indicators of particulate air pollution (PM10,
BS, and sulphate) and SO2 were evaluated
simultaneously, independent eVects were
found more consistently for particles than for
SO2. In children with symptoms who lived in
non-urban areas weaker and less consistent
positive associations were found with indica-
tors of particulate air pollution. No associa-
tions with the gaseous pollutants SO2 and NO2
were found. In children without symptoms, the
daily prevalence of decrements in PEF was
positively correlated with PM10 and BS in both
the urban and non-urban areas. The preva-
lence of URS, cough, and phlegm was not
associated with air pollution in any of the sub-
groups.
In a review article, Dockery and Pope3 com-
bined the results of the then available panel
studies from the United States and Europe,
and calculated that an increase in PM10
concentration of 100 µg/m3 was associated with
increases in the prevalence of LRS and use of
bronchodilators of 30% and 29%, respectively.
Although the definition of LRS was not exactly
the same as in our study, these eVect estimates
correspond well with the ones from our study;
we found that for children with symptoms in
the urban area an increase in same day PM10
concentration was associated with an increase
of 34% and 29% in the prevalence of LRS and
use of bronchodilators, respectively. For URS
and cough, smaller increases of 7% and 12%
were reported by Dockery and Pope.3 Thus,
our study is in agreement with earlier panel
studies as larger relative increases were found
for LRS and use of bronchodilators than for
URS and cough.
Both in the urban and non-urban panels
with symptoms, 5 day mean concentrations
seemed to be more related to indicators of res-
piratory health than present day or lagged
exposure variables. This is in line with other
studies14 16 and suggests that changes in respira-
tory status might reflect cumulative exposure
of several days before the measurement.
Although the children who used medication
in the urban areas increased their use of bron-
chodilators in association with increased parti-
cle concentrations, the strongest increase in
LRS was found in this subgroup. Apparently,
increased use of bronchodilators did not
prevent the adverse eVects of particles on
respiratory health. This is in agreement with
the results of stratified analyses based on use of
medication in a panel study of mildly asthmatic
children in Sokolov, Czech Republic.17 Chil-
dren who used medication increased their use
of â agonists in association with increased par-
ticle concentrations, but this did not prevent
adverse eVects on other health outcomes (in
that case decreases in PEF and increases in the
prevalence of cough).17 The authors speculated
that this was a result of inadequate supplies of
medication for asthma in the Czech Republic.
In The Netherlands, however, this is not a
plausible explanation. Apparently, use of medi-
cation does not prevent the adverse eVects of
particulate air pollution in asthmatic children,
as was suggested in other studies.13 28
Compared with other panel studies, a diVer-
ent approach was used to analyse PEF data,
focusing not on decrements in population
average PEF but on the fraction of children
experiencing substantial decrements in PEF. In
a reanalysis of data from seven panels including
school children with and without symptoms,
Hoek et al15 have compared the two ap-
proaches. It was shown that an increase of 10
µg/m3 of the same day PM10 concentration was
associated with a decrement in the population
mean PEF of 0.07%. A significant increase of
the prevalence of >10% decrements in PEF of
2.7% was associated with the same exposure.
For an increase of 100 µg/m3 this corresponds
to an OR of 1.31, a value very similar to the
ORs found in our study. An advantage of the
approach proposed by Hoek et al15 is that, as in
symptom analysis, it provides eVect estimates
that focus on the fraction of the population
experiencing a specific (adverse) response.
Can some sort of bias have caused the asso-
ciations between particle concentration and
respiratory health found in our study? It is
unlikely that selection processes could have
caused bias in this time series study because
each child served as its own control. Bias due to
the low response may have occurred in the
unlikely case that within the subgroup of
children with and without (chronic respiratory)
symptoms, response was associated with sus-
ceptibility to winter air pollution.
Observer bias in reporting symptoms might
have occurred when parents of the children
were informed by the mass media about
episodes of air pollution. However, during the
study period all concentrations of air pollutants
were below the limits used in the Dutch smog
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alert system, and no warnings were issued.
Potential confounders that might bias the
association between air pollution and respira-
tory health in time series studies are meteoro-
logical variables (mainly ambient tempera-
ture), respiratory infections, and long term
time trends. All associations were adjusted for
ambient temperature and for non-linear long
term time trends (generally in the order of
weeks) in the prevalence of symptoms, use of
bronchodilators, and decrements in PEF. The
adjustment for time trends was more detailed
than in previous panel studies, which either
specified no time trend or a linear trend. The
incidence of influenza-like illness in the general
population, registered by a sentinel system of
general practitioners, was used to adjust for the
potential confounding eVect of respiratory
infections. In previous panel studies, no adjust-
ments for the potential confounding eVect of
respiratory infections were made. We will
report in a separate paper (unpublished data)
that the incidence of influenza-like illness in the
general population was associated with respira-
tory health in selected groups.
In our study, eVects on PEF were somewhat
larger for children with than without symp-
toms. In a previous Dutch study in school chil-
dren, the association between particulate air
pollution and lung function was reported to be
similar in children with and without chronic
respiratory symptoms.7 By contrast, Neas et al18
found that children without chronic respiratory
symptoms seemed to be less susceptible to the
eVects of air pollution on PEF than were chil-
dren with symptoms. Pope and Dockery14
found eVects on PEF in both children with and
without symptoms, but in children with symp-
toms stronger associations were found.
In our study, indices of air pollution were not
associated with respiratory symptoms in the
panels without symptoms, whereas in panels
with symptoms an association with LRS and
use of bronchodilators was found. However,
both LRS and use of bronchodilators were
never or rarely reported in the panels without
symptoms. The finding that indices of air pol-
lution were not associated with respiratory
symptoms in the groups without symptoms is
in agreement with other studies. In two Dutch
studies6 7 no association between particulate air
pollution and respiratory symptoms was found
in mainly healthy school children. Pope and
Dockery14 reported positive associations be-
tween PM10 and the prevalence of URS, LRS,
and cough in both panels with and without
symptoms, but the associations were weaker,
and generally non-significant, in the panels
without symptoms. LRS could be analysed in
the group without symptoms14 because the
definition was diVerent from ours (trouble
breathing, wheeze, and dry cough instead of
shortness of breath, wheeze, asthma attacks).
Thus, children without symptoms seem less
susceptible to the acute eVects of air pollution
than children with symptoms because these do
not develop the asthmatic symptoms that are
most aVected by increasing levels of air
pollution.
It cannot easily be concluded from the one
pollutant models which indicator for air pollu-
tion (PM10, BS, sulphate, or SO2) was most
consistently associated with respiratory health
in the groups, although the associations with
sulphate were less consistent in the panels
without symptoms. Therefore, two pollutant
models evaluating two indicators of air pollu-
tion simultaneously were specified for the pan-
els with symptoms in an attempt to separate
eVects from specific components. The concen-
trations of PM10, BS, sulphate, and SO2 were
intercorrelated, as meteorology is a dominating
factor in determining day to day variations in
concentrations of air pollution. However, as
indicated by the SEMs associated with the
regression coeYcients, this did not lead to col-
linearity problems. The two pollutant models
indicated that SO2 was less consistently associ-
ated with respiratory health than indicators for
particulate air pollution, which was expected
given the low SO2 concentrations that were
found in our study. They also indicated that in
panels with symptoms in the urban areas, PM10
was more consistently associated with health
outcomes than BS and sulphate. Black smoke
can be considered as an indicator of fine black
particles (elemental carbon) emitted by diesel
engines which is generally found in the fine
particle fraction. Sulphate is also present in the
fine fraction and serves as an indicator of
secondary aerosols, representing particles that
mainly result from long range transport. The
finding that the most consistent assocations
were found with PM10 contrasts with two
previous time series studies performed in
Amsterdam which found that BS was more
strongly associated with health outcomes than
PM10.
16 19
In children with symptoms, PM10 and BS
concentrations were more strongly and consist-
ently associated with use of bronchodilators,
and to a lesser extent LRS, in the urban areas
than in the non-urban areas. After stratification
by use of medication it was shown that the dif-
ferences in response between urban and
non-urban groups were restricted to the
children who used medication. We cannot rule
out that diVerences in use of maintenance
medication are responsible for this. Calculated
over the three winters, the mean prevalence of
maintenance medication was almost twofold
lower in the urban areas (8.5%) than in the
non-urban areas (15.5%). As a result, children
in the urban areas might have to rely more on
bronchodilators during periods with high air
pollution than children in the non-urban areas.
Separate analyses for children who used only
bronchodilators during the study period, and
for children who used both bronchodilators
and maintenance medication could show if use
of maintenance medication diminishes the
response to air pollution, but the number of
children that used bronchodilators only was
too small for a meaningful analysis. Moreover,
in such an analysis the amount of maintenance
use of medication by each child during the
study period should be taken in account. The
percentage of the children who used medi-
cation that ever reported use of maintenance
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medication did not diVer between urban and
non-urban panels (76.5% and 78.7%, respec-
tively), but children in the non-urban areas
obviously took their maintenance medication
more often, given the higher prevalence. Thus,
we cannot conclude that the tendency for
stronger eVects of particles on LRS and
especially use of bronchodilators in the urban
areas reflects a more toxic air pollution mixture
in the urban area, as we cannot exclude the
possibility that diVerences in use of medication
are responsible for this.Moreover, in the panels
without symptoms no tendency of stronger
associations in the urban areas was found. The
results of our study are to some extent at vari-
ance with the results of the PEACE study; in 14
urban and 14 non-urban groups with symp-
toms, including the 1993–4 groups of our
study, generally no clear eVects of air pollutants
on PEF, respiratory symptoms, or use of bron-
chodilators were found in the urban and
non-urban panels.20 The main diVerence be-
tween the two studies is that in the Dutch
studies, we were able to combine findings from
three diVerent winter periods whereas in the
PEACE study, the observation period was
about 2 months in one winter only. The Dutch
studies may therefore have been less vulnerable
to the eVect of unmeasured events during that
particular period. Another diVerence is that we
were able to control at least to some extent for
the role of respiratory infections through the
data from the sentinel system of general practi-
tioners on influenza-like illness.
In this study, exposure assessment was based
on fixed site ambient air concentrations
measured at one location in both areas. In the
urban areas, a background location was
selected instead of a site more directly
influenced by traYc emissions, because the
measurement site needed to be representative
for other locations in the study area. It might be
questioned whether exposure to air pollution
was adequately characterised by fixed site
ambient air concentrations only. However, the
resulting misclassification would probably re-
sult in a downward bias of the association
found between air pollution and health end
points. Recent studies in The Netherlands29 30
have shown that the time series correlation
between ambient and personal PM10 was
reasonably high. No consistent diVerences
were found in the strength of the correlation
between ambient and personal PM10 between
children living in Amsterdam and children liv-
ing in the non-industrial small town
Wageningen.29
Transient decrements of FVC and FEV1 of
10% have been considered as the border
between mild and moderate response.31 32 The
eVect estimates found in our study indicate that
in children with symptoms, an increase of 83%
in the number of subjects with a PEF response
of that magnitude was associated with an
increase in 5 day mean PM10 concentration of
100 µg/m3. An increase of 52% was found for
the prevalence of LRS in children with
symptoms, whereas a twofold increase in use of
bronchodilators was associated with a 100
µg/m3 increase in 5 day mean PM10 concentra-
tion. In children without symptoms in both
urban and non-urban areas, particle eVects on
PEF were of smaller magnitude than for
children with symptoms, and no associations
with respiratory symptoms were found.
In conclusion, this study suggests that
children with symptoms are more susceptible
to particulate air pollution than children with-
out symptoms, and that use of medication for
asthma does not prevent the adverse eVects of
particulate air pollution.
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